Current aspects of hepatitis B surface antigen mutants in Singapore

被引:43
作者
Oon, CJ [1 ]
Chen, WN [1 ]
机构
[1] Singapore Gen Hosp, Minist Hlth, Dept Clin Res, Ransome Res Lab, Singapore 169608, Singapore
关键词
antigenicity; hepatocellular carcinoma; HBsAg; HBV; stability; transmission; vaccine-escape mutants;
D O I
10.1046/j.1365-2893.1998.0050s2017.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mutations occurring on the major antigenic 'a' determinant of hepatitis B surface antigen (HBsAg) have been detected in immunized Singapore children, despite immunoprophylaxis with hepatitis B immune globulin and HBV vaccine, These vaccine-escape HBsAg mutants display a predominance of the Gly,,,to-arg,,, mutation in the antigenic 'a' determinant, Our latest follow-up studies indicate the stability of this as well as other vaccine-escape HBsAg mutants over time. We have also identified HBsAg mutants in immunized children with amino acid substitutions outside the 'a' determinant. Transmission of various vaccine-escape HBsAg mutants have been shown in our epidemiological studies. Detection of HBsAg mutants, carrying amino acid changes at various position of the 'a' determinant in random population, points to their emergence in Singapore before the implementation of the vaccination programme. Of significant interest is the recent identification of vaccine-escape HBsAg mutants in hepatocellular carcinoma.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 23 条
[1]   Molecular epidemiology of hepatitis B virus in Central America reflected in the genetic variability of the small S gene [J].
ArauzRuiz, P ;
Norder, H ;
Visona, KA ;
Magnius, LO .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :851-858
[2]  
BEASLEY RP, 1983, LANCET, V2, P1099
[3]   Computer-aided studies on the spatial structure of the small hepatitis B surface protein [J].
Berting, A ;
Hahnen, J ;
Kroger, M ;
Gerlich, WH .
INTERVIROLOGY, 1995, 38 (1-2) :8-15
[4]   VIRAL GENETIC-VARIATION - HEPATITIS-B VIRUS AS A CLINICAL EXAMPLE [J].
CARMAN, W ;
THOMAS, H ;
DOMINGO, E .
LANCET, 1993, 341 (8841) :349-353
[5]   VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].
CARMAN, WF ;
ZANETTI, AR ;
KARAYIANNIS, P ;
WATERS, J ;
MANZILLO, G ;
TANZI, E ;
ZUCKERMAN, AJ ;
THOMAS, HC .
LANCET, 1990, 336 (8711) :325-329
[6]   FULMINANT REACTIVATION OF HEPATITIS-B DUE TO ENVELOPE PROTEIN MUTANT THAT ESCAPED DETECTION BY MONOCLONAL HBSAG ELISA [J].
CARMAN, WF ;
KORULA, J ;
WALLACE, L ;
MACPHEE, R ;
MIMMS, L ;
DECKER, R .
LANCET, 1995, 345 (8962) :1406-1407
[7]  
Carman WF, 1997, HEPATOLOGY, V26, P1658, DOI 10.1002/hep.510260640
[8]   Altered antigenicity of 'a' determinant variants of hepatitis B virus [J].
Chiou, HL ;
Lee, TS ;
Kuo, J ;
Mau, YC ;
Ho, MS .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :2639-2645
[9]   Screening for hepatocellular carcinoma [J].
Collier, J ;
Sherman, M .
HEPATOLOGY, 1998, 27 (01) :273-278
[10]   Hepatitis B immunisation in Singapore [J].
Goh, KT .
LANCET, 1996, 348 (9038) :1385-1386